Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

iwAL 2019 Session IV

Can we truly Integrate MRD Measurement into Clinical Practice?

In Session IV of iwAL 2019, Jorge Sierra, MD, PhD, Peter Valk, PhD and Sylvie Freeman, MBChB, MRCP, DPhil, FRCPath, present talks on MRD in the clinical practice.
E-learning webcasts include risk-adapted trials for AML, MRD guided therapy vs non-MRD guided therapy and MRD as a prognostic tool.

 

Presentations
Risk-adapted trials for AML: The Spanish CETLAM experience
Jorge Sierra
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
4 May, 2019
MRD as a prognostic tool
Sylvie Freeman
University of Birmingham, Birmingham, UK
4 May, 2019
MRD guided therapy vs non MRD guided therapy in adult AML
Peter Valk
Erasmus Medical Center, Rotterdam, The Netherlands
4 May, 2019
Previous session View all sessions Next session
The content of VJHemOnc is intended for healthcare professionals